01:03 , Jan 12, 2019 |  BioCentury  |  Finance

Warning: cash needed

  A near decade-long run of cheap money appears to be coming to a close, and most of the biotech sector isn’t well positioned for the new reality. BioCentury’s analysis shows that two-thirds of biotech...
23:20 , Nov 3, 2016 |  BC Week In Review  |  Financial News

Asarina completes venture financing

Asarina raised €7 million ($7.7 million) in a venture round from Idinvest Partner, Ergomed plc and existing investors. Asarina Pharma AB , Solna, Sweden ...